<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36253101</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1521-1878</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>BioEssays : news and reviews in molecular, cellular and developmental biology</Title><ISOAbbreviation>Bioessays</ISOAbbreviation></Journal><ArticleTitle>Importin &#x3b1;/&#x3b2; and the tug of war to keep TDP-43 in solution: quo vadis?</ArticleTitle><Pagination><StartPage>e2200181</StartPage><MedlinePgn>e2200181</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/bies.202200181</ELocationID><Abstract><AbstractText>The transactivation response-DNA binding protein of 43 kDa (TDP-43) is an aggregation-prone nucleic acid-binding protein linked to the etiology of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Lobar Degeneration (FTLD). These conditions feature the accumulation of insoluble TDP-43 aggregates in the neuronal cytoplasm that lead to cell death. The dynamics between cytoplasmic and nuclear TDP-43 are altered in the disease state where TDP-43 mislocalizes to the cytoplasm, disrupting Nuclear Pore Complexes (NPCs), and ultimately forming large fibrils stabilized by the C-terminal prion-like domain. Here, we review three emerging and poorly understood aspects of TDP-43 biology linked to its aggregation. First, how post-translational modifications in the proximity of TDP-43 N-terminal domain (NTD) promote aggregation. Second, how TDP-43 engages FG-nucleoporins in the NPC, disrupting the pore permeability and function. Third, how the importin &#x3b1;/&#x3b2; heterodimer prevents TDP-43 aggregation, serving both as a nuclear import transporter and a cytoplasmic chaperone.</AbstractText><CopyrightInformation>&#xa9; 2022 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Doll</LastName><ForeName>Steven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cingolani</LastName><ForeName>Gino</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9206-9640</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM122844</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS128396</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM140733</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM122844</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Bioessays</MedlineTA><NlmUniqueID>8510851</NlmUniqueID><ISSNLinking>0265-9247</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D028901">alpha Karyopherins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D028884">Karyopherins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D028901" MajorTopicYN="N">alpha Karyopherins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028884" MajorTopicYN="N">Karyopherins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="Y">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FG-nucleoporins</Keyword><Keyword MajorTopicYN="N">NTD</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword><Keyword MajorTopicYN="N">&#xa0;importin &#x3b1;/&#x3b2;</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST. The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>17</Day><Hour>21</Hour><Minute>45</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36253101</ArticleId><ArticleId IdType="mid">NIHMS1876553</ArticleId><ArticleId IdType="pmc">PMC9969346</ArticleId><ArticleId IdType="doi">10.1002/bies.202200181</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, &#x2026; Lee VM (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314(5796), 130&#x2013;133. doi: 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, &#x2026; Trojanowski JQ (2007). Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol, 61(5), 427&#x2013;434. doi: 10.1002/ana.21147</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, &#x2026; Ule J (2011). Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci, 14(4), 452&#x2013;458. doi: 10.1038/nn.2778</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C, Onesto E, Megiorni F, Pizzuti A, Baralle FE, Buratti E, &#x2026; Ratti A (2012). TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J Biol Chem, 287(19), 15635&#x2013;15647. doi: 10.1074/jbc.M111.333450</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.333450</ArticleId><ArticleId IdType="pmc">PMC3346140</ArticleId><ArticleId IdType="pubmed">22427648</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, McCaffery JM, Lindquist S, &amp; Gitler AD (2008). A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc Natl Acad Sci U S A, 105(17), 6439&#x2013;6444. doi: 10.1073/pnas.0802082105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802082105</ArticleId><ArticleId IdType="pmc">PMC2359814</ArticleId><ArticleId IdType="pubmed">18434538</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, &amp; Lee VM (2008). Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem, 283(19), 13302&#x2013;13309. doi: 10.1074/jbc.M800342200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800342200</ArticleId><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Doll SG, Meshkin H, Bryer AJ, Li F, Ko YH, Lokareddy RK, &#x2026; Cingolani G (2022). Recognition of the TDP-43 nuclear localization signal by importin &#x3b1;1/&#x3b2;. Cell Rep, 39(13), 111007. doi: 10.1016/j.celrep.2022.111007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111007</ArticleId><ArticleId IdType="pmc">PMC9290431</ArticleId><ArticleId IdType="pubmed">35767952</ArticleId></ArticleIdList></Reference><Reference><Citation>Maris C, Dominguez C, &amp; Allain FH (2005). The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression. FEBS J, 272(9), 2118&#x2013;2131. doi: 10.1111/j.1742-4658.2005.04653.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2005.04653.x</ArticleId><ArticleId IdType="pubmed">15853797</ArticleId></ArticleIdList></Reference><Reference><Citation>Berning BA, &amp; Walker AK (2019). The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD. Front Neurosci, 13, 335. doi: 10.3389/fnins.2019.00335</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00335</ArticleId><ArticleId IdType="pmc">PMC6470282</ArticleId><ArticleId IdType="pubmed">31031584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright GSA, Watanabe TF, Amporndanai K, Plotkin SS, Cashman NR, Antonyuk SV, &amp; Hasnain SS (2020). Purification and Structural Characterization of Aggregation-Prone Human TDP-43 Involved in Neurodegenerative Diseases. iScience, 23(6), 101159. doi: 10.1016/j.isci.2020.101159</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101159</ArticleId><ArticleId IdType="pmc">PMC7262455</ArticleId><ArticleId IdType="pubmed">32480125</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T, Hock EM, Ernst P, Foglieni C, Jambeau M, Gilhespy LAB, &#x2026; Polymenidou M (2017). Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat Commun, 8(1), 45. doi: 10.1038/s41467-017-00062-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00062-0</ArticleId><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Mompe&#xe1;n M, Romano V, Pantoja-Uceda D, Stuani C, Baralle FE, Buratti E, &amp; Laurents DV (2016). The TDP-43 N-terminal domain structure at high resolution. FEBS J, 283(7), 1242&#x2013;1260. doi: 10.1111/febs.13651</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13651</ArticleId><ArticleId IdType="pubmed">26756435</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang CH, Grauffel C, Wu LS, Kuo PH, Doudeva LG, Lim C, &#x2026; Yuan HS (2016). Structural analysis of disease-related TDP-43 D169G mutation: linking enhanced stability and caspase cleavage efficiency to protein accumulation. Sci Rep, 6, 21581. doi: 10.1038/srep21581</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep21581</ArticleId><ArticleId IdType="pmc">PMC4756693</ArticleId><ArticleId IdType="pubmed">26883171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo PH, Chiang CH, Wang YT, Doudeva LG, &amp; Yuan HS (2014). The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG- and TG-rich nucleic acids. Nucleic Acids Res, 42(7), 4712&#x2013;4722. doi: 10.1093/nar/gkt1407</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1407</ArticleId><ArticleId IdType="pmc">PMC3985631</ArticleId><ArticleId IdType="pubmed">24464995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo PH, Doudeva LG, Wang YT, Shen CK, &amp; Yuan HS (2009). Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res, 37(6), 1799&#x2013;1808. doi: 10.1093/nar/gkp013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp013</ArticleId><ArticleId IdType="pmc">PMC2665213</ArticleId><ArticleId IdType="pubmed">19174564</ArticleId></ArticleIdList></Reference><Reference><Citation>Arseni D, Hasegawa M, Murzin AG, Kametani F, Arai M, Yoshida M, &amp; Ryskeldi-Falcon B (2022). Structure of pathological TDP-43 filaments from ALS with FTLD. Nature, 601(7891), 139&#x2013;143. doi: 10.1038/s41586-021-04199-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04199-3</ArticleId><ArticleId IdType="pmc">PMC7612255</ArticleId><ArticleId IdType="pubmed">34880495</ArticleId></ArticleIdList></Reference><Reference><Citation>Scial&#xf2; C, Tran TH, Salzano G, Novi G, Caponnetto C, Chi&#xf2; A, &#x2026; Legname G (2020). TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients. Brain Commun, 2(2), fcaa142. doi: 10.1093/braincomms/fcaa142</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa142</ArticleId><ArticleId IdType="pmc">PMC7566418</ArticleId><ArticleId IdType="pubmed">33094285</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Caulfield T, Xu YF, Gendron TF, Hubbard J, Stetler C, &#x2026; Petrucelli L (2013). The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation. Hum Mol Genet, 22(15), 3112&#x2013;3122. doi: 10.1093/hmg/ddt166</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt166</ArticleId><ArticleId IdType="pmc">PMC3699067</ArticleId><ArticleId IdType="pubmed">23575225</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, &#x2026; Petrucelli L (2009). Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci U S A, 106(18), 7607&#x2013;7612. doi: 10.1073/pnas.0900688106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900688106</ArticleId><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano V, Quadri Z, Baralle FE, &amp; Buratti E (2015). The structural integrity of TDP-43 N-terminus is required for efficient aggregate entrapment and consequent loss of protein function. Prion, 9(1), 1&#x2013;9. doi: 10.1080/19336896.2015.1011885</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2015.1011885</ArticleId><ArticleId IdType="pmc">PMC4601194</ArticleId><ArticleId IdType="pubmed">25635624</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiina Y, Arima K, Tabunoki H, &amp; Satoh J (2010). TDP-43 dimerizes in human cells in culture. Cell Mol Neurobiol, 30(4), 641&#x2013;652. doi: 10.1007/s10571-009-9489-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-009-9489-9</ArticleId><ArticleId IdType="pubmed">20043239</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A, Conicella AE, Schmidt HB, Martin EW, Rhoads SN, Reeb AN, &#x2026; Fawzi NL (2018). A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J, 37(5). doi: 10.15252/embj.201797452</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797452</ArticleId><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>Budini M, Romano V, Quadri Z, Buratti E, &amp; Baralle FE (2015). TDP-43 loss of cellular function through aggregation requires additional structural determinants beyond its C-terminal Q/N prion-like domain. Hum Mol Genet, 24(1), 9&#x2013;20. doi: 10.1093/hmg/ddu415</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu415</ArticleId><ArticleId IdType="pmc">PMC4262490</ArticleId><ArticleId IdType="pubmed">25122661</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang LL, Xue W, Hong JY, Zhang JT, Li MJ, Yu SN, &#x2026; Hu HY (2017). The N-terminal dimerization is required for TDP-43 splicing activity. Sci Rep, 7(1), 6196. doi: 10.1038/s41598-017-06263-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-06263-3</ArticleId><ArticleId IdType="pmc">PMC5522446</ArticleId><ArticleId IdType="pubmed">28733604</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Singh R, Kashav T, Yang C, Sharma RD, Lynn AM, &#x2026; Kumar V (2022). Computational Insights of Unfolding of N-Terminal Domain of TDP-43 Reveal the Conformational Heterogeneity in the Unfolding Pathway. Front Mol Neurosci, 15, 822863. doi: 10.3389/fnmol.2022.822863</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2022.822863</ArticleId><ArticleId IdType="pmc">PMC9083116</ArticleId><ArticleId IdType="pubmed">35548668</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretti M, Marzi I, Cantarutti C, Vivoli Vega M, Mandaliti W, Mimmi MC, &#x2026; Chiti F (2022). Conversion of the Native N-Terminal Domain of TDP-43 into a Monomeric Alternative Fold with Lower Aggregation Propensity. Molecules, 27(13). doi: 10.3390/molecules27134309</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27134309</ArticleId><ArticleId IdType="pmc">PMC9268139</ArticleId><ArticleId IdType="pubmed">35807552</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivoli-Vega M, Guri P, Chiti F, &amp; Bemporad F (2020). Insight into the Folding and Dimerization Mechanisms of the N-Terminal Domain from Human TDP-43. Int J Mol Sci, 21(17). doi: 10.3390/ijms21176259</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21176259</ArticleId><ArticleId IdType="pmc">PMC7504384</ArticleId><ArticleId IdType="pubmed">32872449</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti E, &amp; Kuriyan J (2000). Crystallographic analysis of the specific yet versatile recognition of distinct nuclear localization signals by karyopherin alpha. Structure, 8(3), 329&#x2013;338. doi: st8315 [pii]</Citation><ArticleIdList><ArticleId IdType="pubmed">10745017</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontes MR, Teh T, &amp; Kobe B (2000). Structural basis of recognition of monopartite and bipartite nuclear localization sequences by mammalian importin-alpha. J Mol Biol, 297(5), 1183&#x2013;1194. doi: 10.1006/jmbi.2000.3642 S0022&#x2013;2836(00)93642&#x2013;8 [pii]</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.2000.3642</ArticleId><ArticleId IdType="pubmed">10764582</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokareddy RK, Hapsari RA, van Rheenen M, Pumroy RA, Bhardwaj A, Steen A, &#x2026; Cingolani G (2015). Distinctive Properties of the Nuclear Localization Signals of Inner Nuclear Membrane Proteins Heh1 and Heh2. Structure, 23(7), 1305&#x2013;1316. doi: S0969&#x2013;2126(15)00175&#x2013;6 [pii] 10.1016/j.str.2015.04.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2015.04.017</ArticleId><ArticleId IdType="pmc">PMC4768490</ArticleId><ArticleId IdType="pubmed">26051712</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, Zago P, D&#x2019;Ambrogio A, Xu YF, Petrucelli L, Buratti E, &amp; Baralle FE (2008). Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci, 121(Pt 22), 3778&#x2013;3785. doi: 10.1242/jcs.038950</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.038950</ArticleId><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinarbasi ES, Ca&#x11f;atay T, Fung HYJ, Li YC, Chook YM, &amp; Thomas PJ (2018). Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization. Sci Rep, 8(1), 7083. doi: 10.1038/s41598-018-25008-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25008-4</ArticleId><ArticleId IdType="pmc">PMC5935693</ArticleId><ArticleId IdType="pubmed">29728608</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck M, &amp; Hurt E (2017). The nuclear pore complex: understanding its function through structural insight. Nat Rev Mol Cell Biol, 18(2), 73&#x2013;89. doi: 10.1038/nrm.2016.147</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2016.147</ArticleId><ArticleId IdType="pubmed">27999437</ArticleId></ArticleIdList></Reference><Reference><Citation>Aramburu IV, &amp; Lemke EA (2017). Floppy but not sloppy: Interaction mechanism of FG-nucleoporins and nuclear transport receptors. Semin Cell Dev Biol, 68, 34&#x2013;41. doi: 10.1016/j.semcdb.2017.06.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2017.06.026</ArticleId><ArticleId IdType="pmc">PMC7611744</ArticleId><ArticleId IdType="pubmed">28669824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ader C, Frey S, Maas W, Schmidt HB, G&#xf6;rlich D, &amp; Baldus M (2010). Amyloid-like interactions within nucleoporin FG hydrogels. Proc Natl Acad Sci U S A, 107(14), 6281&#x2013;6285. doi: 10.1073/pnas.0910163107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0910163107</ArticleId><ArticleId IdType="pmc">PMC2852002</ArticleId><ArticleId IdType="pubmed">20304795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribbeck K, &amp; G&#xf6;rlich D (2002). The permeability barrier of nuclear pore complexes appears to operate via hydrophobic exclusion. EMBO J, 21(11), 2664&#x2013;2671. doi: 10.1093/emboj/21.11.2664</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/21.11.2664</ArticleId><ArticleId IdType="pmc">PMC126029</ArticleId><ArticleId IdType="pubmed">12032079</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, Zhang Y, Umoh ME, Vaughan SW, Lorenzini I, Liu F, &#x2026; Rossoll W (2018). TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat Neurosci, 21(2), 228&#x2013;239. doi: 10.1038/s41593-017-0047-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Bednenko J, Cingolani G, &amp; Gerace L (2003). Nucleocytoplasmic transport: navigating the channel. Traffic, 4(3), 127&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">12656985</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshizawa T, Ali R, Jiou J, Fung HYJ, Burke KA, Kim SJ, &#x2026; Chook YM (2018). Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites. Cell, 173(3), 693&#x2013;705 e622. doi: 10.1016/j.cell.2018.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.003</ArticleId><ArticleId IdType="pmc">PMC6234985</ArticleId><ArticleId IdType="pubmed">29677513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M, Han TW, Xie S, Shi K, Du X, Wu LC, &#x2026; McKnight SL (2012). Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell, 149(4), 753&#x2013;767. doi: 10.1016/j.cell.2012.04.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.017</ArticleId><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C, Khalil B, Smith CL, &amp; Rossoll W (2020). Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD. Neurobiol Dis, 140, 104835. doi: 10.1016/j.nbd.2020.104835</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104835</ArticleId><ArticleId IdType="pmc">PMC7253339</ArticleId><ArticleId IdType="pubmed">32179176</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukavsky PJ, Daujotyte D, Tollervey JR, Ule J, Stuani C, Buratti E, &#x2026; Allain FH (2013). Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat Struct Mol Biol, 20(12), 1443&#x2013;1449. doi: 10.1038/nsmb.2698</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2698</ArticleId><ArticleId IdType="pubmed">24240615</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavella D, Zitzewitz JA, &amp; Massi F (2018). Characterization of TDP-43 RRM2 Partially Folded States and Their Significance to ALS Pathogenesis. Biophys J, 115(9), 1673&#x2013;1680. doi: 10.1016/j.bpj.2018.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2018.09.011</ArticleId><ArticleId IdType="pmc">PMC6224623</ArticleId><ArticleId IdType="pubmed">30309612</ArticleId></ArticleIdList></Reference><Reference><Citation>Archbold HC, Jackson KL, Arora A, Weskamp K, Tank EM, Li X, &#x2026; Barmada SJ (2018). TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci Rep, 8(1), 4606. doi: 10.1038/s41598-018-22858-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22858-w</ArticleId><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H, Funk C, Abou-Ajram C, Hutten S, Funk EBE, Kehlenbach RH, &#x2026; Dormann D (2018). Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1/CRM1. Scientific reports, 8(1), 7084. doi: 10.1038/s41598-018-25007-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25007-5</ArticleId><ArticleId IdType="pmc">PMC5935713</ArticleId><ArticleId IdType="pubmed">29728564</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E (2018). TDP-43 post-translational modifications in health and disease. Expert Opin Ther Targets, 22(3), 279&#x2013;293. doi: 10.1080/14728222.2018.1439923</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2018.1439923</ArticleId><ArticleId IdType="pubmed">29431050</ArticleId></ArticleIdList></Reference><Reference><Citation>Eck RJ, Kraemer BC, &amp; Liachko NF (2021). Regulation of TDP-43 phosphorylation in aging and disease. Geroscience, 43(4), 1605&#x2013;1614. doi: 10.1007/s11357-021-00383-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-021-00383-5</ArticleId><ArticleId IdType="pmc">PMC8492835</ArticleId><ArticleId IdType="pubmed">34032984</ArticleId></ArticleIdList></Reference><Reference><Citation>Fran&#xe7;ois-Moutal L, Perez-Miller S, Scott DD, Miranda VG, Mollasalehi N, &amp; Khanna M (2019). Structural Insights Into TDP-43 and Effects of Post-translational Modifications. Front Mol Neurosci, 12, 301. doi: 10.3389/fnmol.2019.00301</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00301</ArticleId><ArticleId IdType="pmc">PMC6934062</ArticleId><ArticleId IdType="pubmed">31920533</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, &amp; Skrzypek E (2015). PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res, 43(Database issue), D512&#x2013;520. doi: 10.1093/nar/gku1267</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1267</ArticleId><ArticleId IdType="pmc">PMC4383998</ArticleId><ArticleId IdType="pubmed">25514926</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F, Nonaka T, Suzuki T, Arai T, Dohmae N, Akiyama H, &amp; Hasegawa M (2009). Identification of casein kinase-1 phosphorylation sites on TDP-43. Biochem Biophys Res Commun, 382(2), 405&#x2013;409. doi: 10.1016/j.bbrc.2009.03.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.03.038</ArticleId><ArticleId IdType="pubmed">19285963</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Suzuki G, Tanaka Y, Kametani F, Hirai S, Okado H, &#x2026; Hasegawa M (2016). Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1delta Triggers Mislocalization and Accumulation of TDP-43. J Biol Chem, 291(11), 5473&#x2013;5483. doi: 10.1074/jbc.M115.695379</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.695379</ArticleId><ArticleId IdType="pmc">PMC4786690</ArticleId><ArticleId IdType="pubmed">26769969</ArticleId></ArticleIdList></Reference><Reference><Citation>Kametani F, Obi T, Shishido T, Akatsu H, Murayama S, Saito Y, &#x2026; Hasegawa M (2016). Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains. Sci Rep, 6, 23281. doi: 10.1038/srep23281</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23281</ArticleId><ArticleId IdType="pmc">PMC4793195</ArticleId><ArticleId IdType="pubmed">26980269</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia Morato J, Hans F, von Zweydorf F, Feederle R, Elsasser SJ, Skodras AA, &#x2026; Kahle PJ (2022). Sirtuin-1 sensitive lysine-136 acetylation drives phase separation and pathological aggregation of TDP-43. Nat Commun, 13(1), 1223. doi: 10.1038/s41467-022-28822-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28822-7</ArticleId><ArticleId IdType="pmc">PMC8907366</ArticleId><ArticleId IdType="pubmed">35264561</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruijs da Silva LA, Simonetti F, Hutten S, Riemenschneider H, Sternburg EL, Pietrek LM, &#x2026; Dormann D (2022). Disease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregation. EMBO J, 41(8), e108443. doi: 10.15252/embj.2021108443</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021108443</ArticleId><ArticleId IdType="pmc">PMC9016352</ArticleId><ArticleId IdType="pubmed">35112738</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Kim HJ, Wang H, Monaghan J, Freyermuth F, Sung JC, &#x2026; Shorter J (2018). Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains. Cell, 173(3), 677&#x2013;692 e620. doi: 10.1016/j.cell.2018.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.002</ArticleId><ArticleId IdType="pmc">PMC5911940</ArticleId><ArticleId IdType="pubmed">29677512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutten S, Usluer S, Bourgeois B, Simonetti F, Odeh HM, Fare CM, &#x2026; Dormann D (2020). Nuclear Import Receptors Directly Bind to Arginine-Rich Dipeptide Repeat Proteins and Suppress Their Pathological Interactions. Cell Rep, 33(12), 108538. doi: 10.1016/j.celrep.2020.108538</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108538</ArticleId><ArticleId IdType="pmc">PMC7814465</ArticleId><ArticleId IdType="pubmed">33357437</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M, Hutten S, Bourgeois B, Spreitzer E, Niedner-Boblenz A, Schifferer M, &#x2026; Dormann D (2018). Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation. Cell, 173(3), 706&#x2013;719.e713. doi: 10.1016/j.cell.2018.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.004</ArticleId><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S, Wang G, Randle SJ, Ruggeri FS, Varela JA, Lin JQ, &#x2026; St George-Hyslop P (2018). FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-&#x3c0; Interactions. Cell, 173(3), 720&#x2013;734.e715. doi: 10.1016/j.cell.2018.03.056</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.056</ArticleId><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobe B (1999). Autoinhibition by an internal nuclear localization signal revealed by the crystal structure of mammalian importin alpha. Nat Struct Biol, 6(4), 388&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">10201409</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantoja-Uceda D, Stuani C, Laurents DV, McDermott AE, Buratti E, &amp; Mompe&#xe1;n M (2021). Phe-Gly motifs drive fibrillization of TDP-43&#x2019;s prion-like domain condensates. PLoS Biol, 19(4), e3001198. doi: 10.1371/journal.pbio.3001198</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001198</ArticleId><ArticleId IdType="pmc">PMC8109789</ArticleId><ArticleId IdType="pubmed">33909608</ArticleId></ArticleIdList></Reference><Reference><Citation>Pumroy RA, &amp; Cingolani G (2015). Diversification of importin-alpha isoforms in cellular trafficking and disease states. Biochem J, 466(1), 13&#x2013;28. doi: BJ20141186 [pii] 10.1042/BJ20141186</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20141186</ArticleId><ArticleId IdType="pmc">PMC4405237</ArticleId><ArticleId IdType="pubmed">25656054</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X, Xiang Z, Qin C, Chen Y, Tian H, Meng L, &#x2026; Wang X (2021). Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice. Acta Neuropathol Commun, 9(1), 15. doi: 10.1186/s40478-020-01112-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01112-3</ArticleId><ArticleId IdType="pmc">PMC7814549</ArticleId><ArticleId IdType="pubmed">33461623</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>